...
首页> 外文期刊>Journal of Medical Case Reports >Duodenal enteroglucagonoma revealed by differential comparison of serum and tissue glucagon reactivity with Siemens' Double Glucagon Antibody and DakoCytomation's Polyclonal Rabbit Anti-Human Glucagon: a case report
【24h】

Duodenal enteroglucagonoma revealed by differential comparison of serum and tissue glucagon reactivity with Siemens' Double Glucagon Antibody and DakoCytomation's Polyclonal Rabbit Anti-Human Glucagon: a case report

机译:血清和组织胰高血糖素反应性与西门子双重胰高血糖素抗体和DakoCytomation多克隆兔抗人类胰高血糖素的差异比较揭示了十二指肠肠胰高血糖素:一例病例报告

获取原文
           

摘要

Introduction This case report demonstrates that the differential immunohistochemical reactivities of Siemens' Double Antibody Glucagon compared to DakoCytomation's Polyclonal Rabbit Anti-Human Glucagon allow for pathologic distinction of enteral versus pancreatic glucagonoma. Case presentation A 64-year-old Caucasian man was diagnosed with a duodenal enteroglucagonoma following presentation with obstructive jaundice. He had a low serum glucagon level using Siemens' Double Antibody Glucagon, a clinical syndrome consistent with glucagon hypersecretion. A periampullary mass biopsy proved to be a neuroendocrine tumor, with positive immunohistochemical reactivity to DakoCytomation's Polyclonal Rabbit Anti-Human Glucagon. Conclusions Differential comparison of the immunohistochemical reactivities of Siemens' Double Antibody Glucagon and DakoCytomation's Polyclonal Rabbit Anti-Human Glucagon discerns enteroglucagon from pancreatic glucagon.
机译:简介本病例报告证明,与DakoCytomation的多克隆兔抗人胰高血糖素相比,西门子双重抗体胰高血糖素的免疫组化反应性差异,可以对肠胰高血糖素瘤和胰腺胰高血糖素瘤进行病理学区分。病例报告一名64岁的白种人男子在出现梗阻性黄疸后被诊断出十二指肠肠胰高血糖素瘤。他使用西门子的双重抗体胰高血糖素(一种胰高血糖素分泌过多的临床综合征)的血清胰高血糖素水平较低。壶腹周围的大量活检证明是神经内分泌肿瘤,对DakoCytomation的多克隆兔抗人胰高血糖素有积极的免疫组织化学反应。结论西门子双重抗体胰高血糖素和DakoCytomation的多克隆兔抗人胰高血糖素的免疫组化反应活性的差异比较可从胰高血糖素中分辨出肠胰高血糖素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号